BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/7/2014 5:32:00 PM | Browse: 632 | Download: 708
Publication Name World Journal of Gastroenterology
Manuscript ID 9816
Country/Territory South Korea
Received
2014-03-01 13:06
Peer-Review Started
2014-03-01 19:41
To Make the First Decision
2014-05-29 19:08
Return for Revision
2014-06-03 16:29
Revised
2014-06-16 13:57
Second Decision
2014-07-22 16:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-07-22 17:10
Articles in Press
2014-07-22 18:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-09-11 10:07
Publish the Manuscript Online
2014-10-07 17:32
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title Biological therapy for ulcerative colitis: An update
Manuscript Source Invited Manuscript
All Author List Geom Seog Seo and Soo-Cheon Chae
Funding Agency and Grant Number
Funding Agency Grant Number
Wonkwang University
Corresponding author Soo-Cheon Chae, PhD, Professor, Department of Pathology, Wonkwang University School of Medicine, Digestive Disease Research Institute, 460 Iksandae-ro, Iksan, Cheonbuk 570-749, South Korea. chaesc@wonkwang.ac.kr
Keywords Ulcerative colitis; Immune dysfunction; Biological therapy; Remission; Clinical trial; Inflammatory bowel disease
Core Tip In the last two years, the use of the Janus kinase 3 inhibitor (oral tofacitinib) and the ?4?7 integrin blocker (vedolizumab) reportedly achieved good clinical response and remission rates in ulcerative colitis patients. Thus, we believe that the detailed investigation of various studies on clinical trials performed thus far may provide important information for the selection of appropriate biological agents, and therefore, we have extensively reviewed such trials in the present study.
Publish Date 2014-10-07 17:32
Citation Seo GS, Chae SC. Biological therapy for ulcerative colitis: An update. World J Gastroenterol 2014; 20(37): 13234-13238
Url http://www.wjgnet.com/1007-9327/full/v20/i37/13234.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i37.13234
Full Article (PDF) WJG-20-13234.pdf
Full Article (Word) WJG-20-13234.doc
Manuscript File 9816-Review.docx
Answering Reviewers 9816-Answering reviewers.PDF
Copyright License Agreement 9816-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate 9816-Language certificate.pdf
Peer-review Report 9816-Peer review(s).pdf
Scientific Misconduct Check 9816-CrossCheck.jpg
Scientific Editor Work List 9816-Scientific editor work list.pdf